English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background: Pseudo Tumor Cerebri (PTC), also known by the name Idiopathic Intracranial Hypertension (IIH), is a disorder with increased intracranial pressure (ICP) and associated headache, nausea, vomiting, transient visual obscuration, double-vision, and visual field defects. Material and methods: Thirty-four cases of idiopathic intracranial hypertension reported to our institute, all reported people are female, and all are over twenty years of age, with a diagnosis of IIH according to the Modified dandy criteria were included and treated medically with oral acetazolamide at a dose of 500 mg/day. Results: All patients are started on oral acetazolamide 250 mg twice daily; all patients got resolved of fundus changes and nerve palsy with the therapy within three months of follow up. Conclusions: In this study, administration of low doses of acetazolamide 250mg twice daily for a duration of 3 months for all the patients, and there were no signs of recurrence after cessation of acetazolamide and in the further followup. Acetazolamide plays an important role in cases of IIH for its best outcome. Early diagnosis and early treatment with acetazolamide gave good outcomes in all cases of Idiopathic Intracranial Hypertension.

A Case Study on Idiopathic Intracranial Hypertension Management and Outcome.